Jeff Aycock
About Jeff Aycock
Jeff Aycock serves as the Vice President of Clinical Operations at Instil Bio, a position he has held since 2019. He has extensive experience in clinical operations, having previously worked at Kite Pharma and Amgen in various leadership roles.
Work at Instil Bio
Jeff Aycock has served as Vice President of Clinical Operations at Instil Bio since 2019. His role involves overseeing clinical operations and ensuring the effective execution of clinical trials. Based in Los Angeles, California, he has contributed to the company's mission of advancing cell therapy for cancer treatment. His leadership in clinical operations supports the development of innovative therapies aimed at improving patient outcomes.
Previous Experience at Kite Pharma
Prior to his current position, Jeff Aycock worked at Kite Pharma, Inc. in various roles. He was Senior Director of Clinical Operations from 2014 to 2016 and then served as Vice President of Clinical Operations from 2016 to 2019. During his tenure, he was involved in managing clinical trials and operational strategies that supported the company's growth in the field of oncology.
Career at Amgen
Jeff Aycock has a significant history with Amgen, where he held multiple roles. He worked as Senior Manager, Clinical Program Manager from 2005 to 2007, and later as Director of Clinical Development from 2007 to 2014. His responsibilities included overseeing clinical research initiatives and managing teams to drive the development of new therapies. He also served as Manager of Clinical Research from 2001 to 2005.
Early Career and Education
Jeff Aycock began his career in clinical research at PAREXEL as a Clinical Research Associate from 1997 to 1998. He then joined Pfizer as a Senior Clinical Research Associate from 1998 to 2001. He holds a degree from California Lutheran University, where he studied from 1992 to 1995. His educational background laid the foundation for his extensive career in clinical operations and research.